About Kat Kayser-Bricker
Form D filings for Modifi Biosciences from 2023 to 2024 list Kat Kayser-Bricker as director.
Kat Kayser-Bricker first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Kat Kayser-Bricker in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kat Kayser-Bricker works with at each company, as listed on that company's latest Form D.
Modifi Biosciences, Inc. · Form D, Aug 29, 2024